Independent reference · Facts sourced from CPSC, ENERGY STAR and DOE Record verified Aug 18, 2026
ItemRecalls.com
Active recall — stop using this product now.
Remedy: free repair · About 73,000 units
Recall No. 20-091 Published March 18, 2020

Sandimmune® (cyclosporine capsules, USP) 100 mg soft gelatin capsules and Neoral® (cyclosporine capsules, USP) MODIFIED 100 mg soft gelatin capsules prescription drug blister packages

The prescription drug packaging is not child resistant as required by the Poison Prevention Packaging Act (PPPA), posing a risk of poisoning if the contents are swallowed by young children. sold at Clinics and pharmacies nationwide as a prescribed medicine from March 2018 – March 2020.

View the official CPSC notice Watch this model Jump to the remedy
Recalled Neoral® 100 mg soft gelatin capsules
What you are looking at

Recalled Neoral® 100 mg soft gelatin capsules

Image: CPSC recall notice Two more views

Check the label first

Compare every letter, number, space and suffix. A similar-looking product with a different suffix may not be part of this recall.

Affected model numbers

Why it was recalled

The prescription drug packaging is not child resistant as required by the Poison Prevention Packaging Act (PPPA), posing a risk of poisoning if the contents are swallowed by young children.

0
Incident reports to the firm
0
Injuries reported
0
SaferProducts.gov reports

None reported.

The official remedy

Remedy type: repair
01
What to do

Consumers should immediately secure the product out of the sight and reach of children and contact the firm to request a free child-resistant pouch in which to store the blister package medications. Consumers can continue to use the medication as directed. The child-resistant pouches should be used to store these medications until new child-resistant blister packaging is available.

Product and sales details

UnitsAbout 73,000
Made inUnited States
Sold atClinics and pharmacies nationwide as a prescribed medicine
Sales periodMarch 2018 – March 2020

How to reach the firm

Phone
866-629-6182
8 a.m. to 8 p.m. ET daily
Email

Verify phone numbers, hours and web addresses on the current CPSC notice before contacting the firm.